CompletedPhase 3NCT01117298

A Randomized Control Trial to Assess the Efficacy of Tadalafil in Raynaud's Phenomenon in Scleroderma

Studying Diffuse cutaneous systemic sclerosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Sanjay Gandhi Postgraduate Institute of Medical Sciences
Principal Investigator
Parasar Ghosh, MD, DM
IPGMER, Kolkatta
Intervention
Tadalafil(drug)
Enrollment
66 enrolled
Eligibility
18-65 years · All sexes
Timeline
2009 – 2010

Study locations (4)

Collaborators

Institute of Postgraduate Medical Education and Research · Post Graduate Institute of Medical Education and Research, Chandigarh · Army Hospital Research And Referral, India

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01117298 on ClinicalTrials.gov

Other trials for Diffuse cutaneous systemic sclerosis

Additional recruiting or active studies for the same condition.

See all trials for Diffuse cutaneous systemic sclerosis →

← Back to all trials